Guyana Early Warning System - EWS - Rapid Alerts

Guyana Early Warning System - EWS - Rapid Alerts Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Guyana Early Warning System - EWS - Rapid Alerts, Public & Government Service, Homestretch Avenue, Georgetown.

The Guyana EWS is a national Law Enforcement and public health safeguard that connects law enforcement, laboratories, health services, and policy institutions to rapidly detect, assess, and respond to emerging drug threats.

Incident SummaryOfficers of the Customs Anti Narcotic Unit (CANU) have received critical intelligence regarding the impo...
11/08/2026

Incident Summary

Officers of the Customs Anti Narcotic Unit (CANU) have received critical intelligence regarding the importation of a highly addictive smokeless to***co product into Guyana. The product is commercially packaged and labelled as "Chimó El Tigrito."
Recent investigations reveal that this product is being distributed in small, yellow, round containers marked as 18 grams. The packaging misrepresents the severity of the product, making it appear innocuous or similar to candy, which significantly increases its appeal to youth and adolescents. This alert is issued as a precautionary public health notification to support enhanced surveillance, reporting, and risk assessment. There is currently no laboratory confirmation that the product contains controlled substances, novel psychoactive substances (NPS), or other illicit adulterants. Investigations and laboratory analyses are ongoing.
Reason for Alert Level 3 (Moderate):

Credible intelligence confirms the product has entered Guyana.

The product contains high concentrations of ni****ne and poses potential health risks.

Laboratory analysis is pending.

No poisoning incidents or confirmed adverse events have been reported in Guyana to date.

Enhanced monitoring is warranted to detect any emerging public health or law enforcement concerns.

What is Chimó?

Chimó is a traditional smokeless to***co preparation originating from the Andean region of Venezuela. It is a thick, dark paste or jelly made from cured to***co leaves (Nicotiana tabacum), sodium bicarbonate, brown sugar, ashes from the Mamón tree (Melicoccus bijugatus), and vanilla or other flavourings.

Unlike chewing to***co or s***f, chimó is typically placed between the lip or cheek and the gums, where the user leaves it for an extended period. The saliva mixes with the paste, and the ni****ne is rapidly absorbed through the oral mucosa directly into the bloodstream.

The Danger of Ni****ne Content
Smokeless to***co products like chimó contain exceptionally high levels of ni****ne. In fact, smokeless to***co can deliver up to twice as much ni****ne as an average combustible cigarette. This makes it highly addictive and particularly dangerous for young, developing brains.

Public Health & School Safety Risks
The introduction of "Chimó El Tigrito" into Guyana poses a multi-faceted threat to public health, with a specific and alarming focus on school-aged children.

Youth Targeting and School Safety

Deceptive Packaging: The bright yellow packaging and small size (18g) mimic candy or mint containers, masking the dangerous nature of the substance from parents and teachers.

Flavoured Formulations: The addition of flavourings (such as cherry or vanilla) reduces the harsh taste of to***co, making it highly palatable to children and adolescents.

Academic Impact: Ni****ne addiction in youth is linked to cognitive impairment, reduced attention span, increased anxiety, and a decline in school performance and productivity

Gateway Effect: Youth who initiate ni****ne use with smokeless to***co are significantly more likely to transition to combustible ci******es or electronic va**ng devices later in life
These products present a serious threat to youths, as packaging is colourful and commercially designed to attract minors.

Severe Health Consequences

Ni****ne Poisoning: Due to the high concentration of ni****ne, accidental ingestion or excessive use by children can lead to acute ni****ne poisoning. Symptoms include nausea, vomiting, dizziness, tremors, and in severe cases, seizures or respiratory failure

Carcinogenic Exposure: Smokeless to***co contains numerous cancer-causing chemicals, most notably to***co-specific nitrosamines (TSNAs). These compounds are directly linked to cancers of the mouth, throat, oesophagus, and pancreas.

Cardiovascular Strain: The rapid absorption of high-dose ni****ne causes immediate spikes in heart rate and blood pressure, increasing the risk of irregular heartbeats (arrhythmias) and sudden cardiac events.

Physical Side Effects of Smokeless To***co Use

Continued use of chimó and similar smokeless to***co products results in severe and often irreversible physical damage, particularly to oral health.

Category-Specific Side Effects

Oral & Dental Health

Severe bad breath (halitosis)

Deep tooth discolouration

Gum recession and periodontal disease

Loose teeth and accelerated tooth decay

Chronic, painful mouth sores

Pre-Cancerous Conditions

Leukoplakia: Thick, white or grey patches forming on the gums, inside of the cheeks, or bottom of the mouth that cannot be scraped off. These lesions have a high potential to become malignant.

Systemic Effects

Elevated blood pressure (hypertension)

Increased resting heart rate

Ni****ne dependence and severe withdrawal symptoms (irritability, anxiety, cravings)

Current Situation in Guyana
The EWS has received information that this product has entered Guyana through importation.

At present:

There is no evidence linking this product to overdoses or poisoning incidents in Guyana.

There is no laboratory evidence confirming the presence of illicit drugs or novel psychoactive substances.

Authorities are actively monitoring the situation and gathering additional information.

Members of the Public

Avoid using unfamiliar to***co products of unknown composition.

Keep the product out of the reach of children.

Seek immediate medical attention if accidental ingestion occurs, especially by children.

If you or someone you know is using this product:

Discard Immediately: Safely dispose of all smokeless to***co products.

Seek Medical Support: Consult a healthcare provider or visit a local health clinic for a professional evaluation of oral health and ni****ne dependence.

Utilise Healthy Alternatives: Replace the physical habit of oral to***co with healthier options such as sugar-free gum, sunflower seeds, pumpkin seeds, or apple slices.

Build a Support System: Inform family, friends, teachers, and coaches about the decision to quit to ensure accountability and encouragement.

Engage in Positive Activities: Redirect energy into hobbies, physical activities, sports, or volunteering to manage withdrawal symptoms and cravings.

Important Notice

This alert is issued as a precautionary public health notification to support surveillance and informed decision-making. The information is based on credible intelligence received by the Guyana Early Warning System. The alert does not imply that the product is illegal or adulterated, and further laboratory analysis and regulatory assessment are ongoing. The alert will be updated as additional evidence becomes available.

15/07/2026

⚠️🫁 BREAKTHROUGH NEWS: Doctors just announced that va**ng has been conclusively linked to permanent lung disease.

Sadly, many teens have already been diagnosed.

Diacetyl, or 2,3-butanedione, is a flavouring agent that becomes a toxic inhalant when aerosolised. It causes inflammation and scarring in the bronchioles (the smallest branches of the lungs).

This makes it extremely difficult for air to move through.

The result? Permanent and often disabling lung damage.

learn more https://theconversation.com/popcorn-lung-how-va**ng-could-scar-your-lungs-for-life-254414

What are your thoughts on this research? Were you aware of these potential risks?

For educational purposes. This content is based on publicly available scientific research.

GUYANA EARLY WARNING SYSTEM ISSUES ALERT ON SYNTHETIC DRUG THREAT NOTICE – M**A & CRYSTAL METHAMPHETAMINEDATE: 13TH MAY ...
14/05/2026

GUYANA EARLY WARNING SYSTEM ISSUES ALERT ON SYNTHETIC DRUG THREAT NOTICE – M**A & CRYSTAL METHAMPHETAMINE
DATE: 13TH MAY 2026

The Customs Anti Narcotic Unit (CANU), through the Guyana Drug Information Network (GUYDIN) and the Early Warning System (EWS), is alerting the public to the emerging threat posed by the suspected circulation of synthetic stimulant drugs, including M**A (Ecstasy) and Crystal Methamphetamine (“Crystal Meth” / “Ice”), within Guyana.

Recent intelligence-led operations resulted in the seizure of suspected M**A and crystalline substances consistent with methamphetamine hydrochloride. Preliminary field testing indicated the presence of amphetamine-type stimulants, while forensic confirmation remains ongoing.

Authorities are particularly concerned about:

• Possible distribution within nightlife and youth environments
• Synthetic drugs being disguised or mixed with other substances
• Increased risks of overdose, psychosis, seizures, violent behaviour, and severe addiction
• Organised criminal trafficking networks exploiting entertainment and transport channels

CANU strongly advises the public not to consume, handle, transport, or purchase unknown pills, crystals, powders, or “party drugs.” These substances may contain dangerous adulterants and unpredictable chemical compositions capable of causing serious injury or death.

Parents, schools, healthcare providers, transport operators, nightlife establishments, and community leaders are urged to remain vigilant and report suspicious drug-related activity to law enforcement authorities immediately.

GUYANA EARLY WARNING SYSTEM ISSUES ALERT ON EMERGING PSYCHOACTIVE GUMMIESDATE: 13TH MAY, 2026The Customs Anti Narcotic U...
14/05/2026

GUYANA EARLY WARNING SYSTEM ISSUES ALERT ON EMERGING PSYCHOACTIVE GUMMIES
DATE: 13TH MAY, 2026

The Customs Anti Narcotic Unit (CANU), through the Guyana Drug Information Network (GUYDIN) and the national Early Warning System (EWS), has issued a Level 2 – Emerging Circulation Confirmed Alert following the seizure of suspected psychoactive gummy products at the Cheddi Jagan International Airport (CJIA).

The products, marketed as “Mushroom Gummies” and “Entheogenic Nootropic Blend Gummies,” were intercepted during passenger screening operations. Preliminary assessments indicate the products may contain THCP and other emerging psychoactive compounds.

Authorities are warning the public that these brightly packaged edible products may pose serious health risks, including hallucinations, severe intoxication, panic reactions, psychosis, and impaired judgment. Internationally, THCP-related products have been associated with unpredictable and potentially dangerous effects.

CANU further reminds the public that products labelled as “hemp-derived,” “natural,” or “wellness” supplements are not exempt from enforcement scrutiny under the laws of Guyana.

The seizure highlights the growing regional and international trend involving novel psychoactive substances (NPS) disguised as edible or wellness products and marketed online, particularly to youths and young adults.

Investigations remain ongoing, and the products have been secured for forensic analysis. CANU urges parents, schools, retailers, and the wider public to remain vigilant and report suspicious psychoactive products to the relevant authorities.

EARLY WARNING ALERTA dangerous drug product identified in Guyana contained Delta-9-THC, Delta-8-THC, suspected synthetic...
15/04/2026

EARLY WARNING ALERT
A dangerous drug product identified in Guyana contained Delta-9-THC, Delta-8-THC, suspected synthetic cannabinoids, and herbal carrier material, which was discovered by Officers of the Customs Anti-Narcotic Unit during an operation. This is a major warning sign of chemically altered products being disguised as natural substances. Not all w**d is actually w**d anymore. Stay alert and protect your community.

GUYANA EARLY WARNING SYSTEM ALERT
A dangerous product was identified containing:
• Delta-9-THC
• Delta-8-THC
• Suspected synthetic cannabinoids
Mixed into herbal material.

WHAT WAS FOUND?
A seized product in Guyana showed:
• THC
• Delta-8-THC
• Suspected synthetic cannabinoids
• Herbal carrier material (Marshmallow Leaf)
This means the substance may look harmless, but it is not.

WHY THIS IS SERIOUS
Synthetic cannabinoids can be far more dangerous than natural cannabis.
Risks may include:
• Severe anxiety or panic
• Psychosis
• Seizures
• Hallucinations
• Cardiac stress
• Loss of consciousness
• Death in extreme cases

THE DECEPTION
This product may be disguised as a natural herbal product or tea.
That makes it easier to:
• Hide
• Sell
• Mislead users
• Avoid suspicion

KEY WARNING SIGNS
Authorities are seeing:
• Synthetic cannabinoids mixed with herbal material
• Delta-8, Delta-9, and synthetics together
• A shift from traditional cannabis to engineered products
• Higher risk of mass intoxication incidents

PUBLIC HEALTH RISK
These products are unpredictable.
Potency may vary across the same batch.
One portion may seem weak. Another may be dangerously concentrated.

STAY ALERT. STAY SAFE.
Unknown herbal products can carry serious risks.
Report suspicious products or unusual reactions through the proper channels.
Customs Anti Narcotic Unit – Guyana Early Warning System

Hashtags:

🚨 PUBLIC ALERT: THC-INFUSED DRINKS SEIZED AT CJIA 🚨CANU is warning the public following the seizure of 222 THC-infused b...
19/03/2026

🚨 PUBLIC ALERT: THC-INFUSED DRINKS SEIZED AT CJIA 🚨

CANU is warning the public following the seizure of 222 THC-infused beverages at the Cheddi Jagan International Airport.

These products were hidden inside cargo shipments and are designed to look like regular soft drinks, making them especially dangerous, particularly for young people.

⚠️ IMPORTANT:
Cannabis and all cannabis-derived products, including THC drinks, are ILLEGAL in Guyana. Possession, importation, or distribution can lead to serious criminal charges.

🧠 Health Risks Include:

Impaired judgment

Panic attacks & hallucinations

Accidental overdose

Increased risk for youth exposure

🚫 DO NOT BUY OR CONSUME UNKNOWN DRINKS
👀 Be alert to suspicious imported beverages
📢 Report any information to CANU immediately

Reports can be made confidentially via
Tel: 592-227-3503 / 592-226-0431
Email: [email protected]

This is a new and emerging drug trend, and we are taking strong action to protect the public.

Early warning system drug alert:3,4-methylenedioxymethamphetamine (M**A)INCIDENT SUMMARYOn Wednesday, February 4, 2026, ...
06/02/2026

Early warning system drug alert:
3,4-methylenedioxymethamphetamine (M**A)

INCIDENT SUMMARY
On Wednesday, February 4, 2026, at approximately 10:46 hrs, The Guyana Police, Regional Division #2 responded to a report from a secondary school on the Essequibo Coast where several small transparent zip-lock bags containing a substance suspected to be Methylenedioxymethamphetamine (M**A), commonly known as “Molly,” were discovered in the possession of two students and inside a classroom. The suspected narcotics were seized and weighed, amounting to 5.82 grams, and subsequently lodged as evidence. Two juveniles, aged 14 and 15, were taken to the police station in the presence of school officials, their parents, and a welfare officer, while a 20-year-old male was later arrested and remains in custody as investigations continue.

PRELIMINARY RESULTS
Preliminary Test conducted by Officers confirmed the presence of:
3,4-Methylenedioxymethamphetamine (M**A), A Schedule I controlled substance under the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10.

THREAT INDICATORS & EARLY WARNING SIGNALS
• Confirmed circulation of M**A tablets within commercial entertainment zones
• Distribution pattern consistent with nightlife and youth-targeted micro-trafficking
• Amphetamine-type stimulants remain rare in Guyana, making this detection significant
• Potential for increased demand due to nightlife, parties, or imported supply streams
• High-risk profile due to dosing variability and unknown adulterants

WHAT IS METHYLENEDIOXYMETHAMPHETAMINE (M**A)
3,4-methylenedioxymethamphetamine (M**A) is a stimulant and hallucinogen, eliciting an invigorating impact, alterations in temporal and perceptual experiences, and heightened pleasure in tactile sensations.

PUBLIC HEALTH & SAFETY RISKS
• Pills may contain varying concentrations, increasing overdose risk
• Possible adulteration with caffeine, methamphetamine, synthetic cathinones, or other stimulants
Users may experience:
• Rapid heart rate
• Hyperthermia (dangerous overheating)
• Confusion, agitation
• Risk of collapse, seizures, or severe dehydration
• A greater danger when combined with alcohol or other drugs

PSYCHOLOGICAL SIDE EFFECTS AND RISKS OF M**A
• Anxiety and panic attacks
• Confusion
• Depression
• Drug cravings
• Loss of appetite
• Memory and attention difficulties
• Paranoia
• Sleep difficulties

PHYSICAL SIDE EFFECTS OF M**A:
• Blurred vision
• Chills
• Dangerous increase in body temperature (hyperpyrexia)
• Dehydration, which can be severe
• Feeling faint
• High blood pressure (hypertension)
• Muscle tension and cramping
• Nausea and vomiting
• Restless legs
• Sweating
• Tremors

WITHDRAWAL
The effects of ecstasy often persist for 3-6 hours; however, individuals may administer a further dose when the effects of the previous dose diminish or engage in a binge pattern, consuming multiple doses consecutively. Following around one week of such usage, individuals may have difficulties like irritability, impulsivity, sleep disruptions, anxiety, memory and attention deficits, and diminished motivation in sexual activity.
Upon cessation of ecstasy usage, certain individuals with a history of recurrent use report experiencing withdrawal symptoms, which may encompass:

● Fatigue.
● Depression.
● Difficulty concentrating.
● Loss of appetite.
● Sleep issues.
● Anxiety.
● Irritability.

RECOVERY
Although the United States Food and Drug Administration (FDA) has not yet approved any drugs for the treatment of ecstasy addiction, medical detox can create a stable, safe environment in which any remaining acute intoxication and ecstasy withdrawal can be managed more effectively.18 Detox is typically the first step towards recovery and is insufficient on its own to support long-term rehabilitation. As a result, treatment continues after detox and can take place in a variety of settings.
Inpatient rehab centres offer high-quality care and may be effective if you have a history of polysubstance abuse or co-occurring mental health disorders. You will reside on-site and receive several therapies, along with round-the-clock support and monitoring.
Outpatient rehabilitation allows you to live at home or in a sober-living facility while receiving treatment one to several times each week. It may be an appropriate alternative if you have a supportive home environment or require less intensive treatment.
Cognitive-behavioural therapy is the primary treatment for ecstasy addiction. These approaches help people change beliefs and behaviours that contribute to substance abuse and teach healthy coping strategies for stress and other life challenges. Cognitive-behavioural therapies can be delivered in individual counselling sessions or in group therapy. Mutual-help groups can be an effective complement to cognitive-behavioural therapy, as they provide support from people who are also in recovery.
RECOMMENDED ACTIONS (AGENCIES & STAKEHOLDERS)
LAW ENFORCEMENT
• Increase patrols and surveillance in entertainment hubs

• Monitor micro-distribution networks and vehicle-based supply points

• Strengthen intelligence-sharing with venue security teams

HEALTH SECTOR
• Alert emergency departments to potential M**A-related presentations

• Monitor for clusters of acute intoxication

• Ensure rapid reporting to GUYDIN/EWS

EDUCATION & PREVENTION AGENCIES
• Issue youth-friendly advisories

• Integrate stimulant-risk messaging into school and tertiary outreach

• Engage nightlife operators for awareness support

ADDITIONAL CONSIDERATIONS REGARDING SEIZED PRODUCTS
See the picture below.
In accordance with Schedule I of the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, ecstasy (M**A) is classified as a prohibited substance under the laws of Guyana. Any criminal offence involving the possession, trafficking, or distribution of ecstasy is illegal.

EWS NOTICE LEVEL
⚠️ Level 3 - Emerging Circulation Confirmed
M**A has been forensically validated and detected in a context suggesting active distribution. Continued monitoring is required.

REFERENCES
https://americanaddictioncenters.org/ecstasy-abuse/withdrawal-symptoms
https://www.dea.gov/sites/default/files/2025-01/Ecstasy-M**A-2024-Drug-Fact-Sheet.pdf
https://www.webmd.com/mental-health/addiction/what-is-ecstasy

PUBLIC DRUG ALERTGuyana National Early Warning System (EWS)Issued: 27 January 2026The Guyana National Early Warning Syst...
29/01/2026

PUBLIC DRUG ALERT
Guyana National Early Warning System (EWS)
Issued: 27 January 2026

The Guyana National Early Warning System (EWS), coordinated through the Customs Anti-Narcotic Unit (CANU), wishes to inform the general public of the detection of pills suspected to be M**A (commonly known as “ecstasy”) within Guyana.

During a law-enforcement operation conducted at Tabatinga, Lethem, officers discovered tablets which, upon preliminary field testing, showed a positive indication for amphetamine-type stimulants, consistent with M**A. Further analysis is ongoing.

Public Health and Safety Advisory

M**A is a controlled substance under the Narcotic and Psychotropic Substances (Control) Act, Chapter 10:10, and its possession, use, distribution, or trafficking is illegal in Guyana.

The use of M**A poses serious health risks, particularly because:

The strength and composition of tablets are unpredictable

Pills may be mixed with other harmful substances

Risks increase significantly when combined with alcohol or other drugs

Reported adverse effects may include:

Rapid heart rate and elevated blood pressure

Dangerous overheating (hyperthermia)

Severe dehydration

Confusion, agitation, collapse, seizures, or loss of consciousness

Guidance to the Public

Members of the public are strongly advised not to consume unknown or illicit pills marketed as “ecstasy,” “M**A,” or similar names.

Anyone experiencing severe symptoms after suspected drug use should seek immediate medical attention.

Information relating to the sale, distribution, or movement of illicit drugs should be reported to CANU or the nearest police station.

Ongoing Monitoring

The Guyana EWS continues to monitor emerging drug trends and will issue further advisories as necessary to protect public health and safety.

This alert is issued in the interest of public awareness and harm prevention.

Reports can be made confidentially via
Tel: 592-227-3503 / 592-226-0431
Email: [email protected]

FOR IMMEDIATE CIRCULATIONCUSTOMS ANTI NARCOTIC UNIT (CANU)Guyana National Drug AuthorityCannabis v**e cartridges discove...
15/01/2026

FOR IMMEDIATE CIRCULATION

CUSTOMS ANTI NARCOTIC UNIT (CANU)
Guyana National Drug Authority

Cannabis v**e cartridges discovered, Issues National Early Warning Alert
On the 15th January, 2026, based on intelligence received, CANU Officers conducted an operation in Campbellville Housing Scheme, Georgetown, which resulted in the discovery and seizure of multiple branded THC cannabis v**es.
The seizure indicates an emerging shift toward the importation of high-potency cannabis concentrates disguised as consumer v**e products. The packaging is colourful, professionally printed, and designed to appeal to youths, increasing the risk of rapid spread if circulation is not contained. Chemical composition and potential contaminants remain unknown, and samples have been earmarked for laboratory analysis.
Under Guyana’s laws, these substances are 100% illegal regardless of packaging, branding, or foreign “medical use” labels.

WHY IS IT ILLEGAL
Under the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, cannabis and its derivatives are listed as controlled substances.
This classification includes the cannabis plant, cannabis resin, extracts and tinctures of cannabis, THC (tetrahydrocannabinol), and any product containing THC.
Live resin and THC v**e oil fall directly under cannabis resin and extracts, which are prohibited. Therefore, possession, trafficking, importation, or sale is illegal in Guyana.

The “for medical use only” labels on the boxes have no legal standing in Guyana and do not change the fact that the products are prohibited.

NO APPROVING LABELS

None of these labels corresponds to:

• The Guyana Food and Drug Department

• Any local licensing authority

• GFSL testing

• Any legal cannabis framework in Guyana

HEALTH EFFECTS OF CANNABIS VAPES

Cannabis v**es expose users to high concentrations of THC and unknown chemical additives, which can cause serious short-term and long-term health problems. Because these products are often unregulated or counterfeit, the risks are significantly higher.

GUYANA - EWS

Guyana’s Early Warning System (EWS), housed within the Customs Anti Narcotic Unit, also identifies these THC cartridges as high-risk emerging threats, particularly to minors. The EWS tracks trends, packaging styles, chemical profiles, and trafficking patterns linked to concentrated cannabis products. Once flagged, the system issues alerts, guides frontline officers, and feeds actionable intelligence into national enforcement operations.

Reports can be made confidentially via
Tel: 592-227-3503 / 592-226-0431
Email: [email protected]

Address

Homestretch Avenue
Georgetown
592

Website

Alerts

Be the first to know and let us send you an email when Guyana Early Warning System - EWS - Rapid Alerts posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Guyana Early Warning System - EWS - Rapid Alerts:

Shortcuts

Share